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Laser in-situ keratomileusis (LASIK) is a commonly performed surgical procedure used to correct refractive error.
LASIK surgery involves cutting a corneal flap and ablating the stroma underneath, with known damage to corneal
nerves. Despite this, the epidemiology of persistent pain and other long-term outcomes after LASIK surgery are not
well understood. Available data suggest that approximately 20-55% of patients report persistent eye symptoms
(generally regarded as at least 6 months post-operation) after LASIK surgery. While it was initially believed that these
symptoms were caused by ocular surface dryness, and referred to as “dry eye,” it is now increasingly understood
that corneal nerve damage produced by LASIK surgery resembles the pathologic neuroplasticity associated with
other forms of persistent post-operative pain. In susceptible patients, these neuropathological changes, including
peripheral sensitization, central sensitization, and altered descending modulation, may underlie certain persistent
dry eye symptoms after LASIK surgery. This review will focus on the known epidemiology of symptoms after LASIK
and discuss mechanisms of persistent post-op pain due to nerve injury that may be relevant to these patients.
Potential preventative and treatment options based on approaches used for other forms of persistent post-op pain
and their application to LASIK patients are also discussed. Finally, the concept of genetic susceptibility to post-LASIK
ocular surface pain is presented.
Keywords: LASIK, Photorefractive keratectomy, Dry eye, Chronic pain, Neuropathic pain, Persistent post-operative
pain, Photoallodynia, Peripheral sensitization, Central sensitizationIntroduction: Ocular nerve injury after LASIK and
evidence for persistent ocular pain
Laser in-situ keratomileusis (LASIK) is a common pro-
cedure to correct refractive error, with approximately
650,000 cases performed in the US each year [1]. LASIK
involves the creation of a superficial flap of corneal epi-
thelium and anterior stroma, which is retracted to allow
for the ablation of the underlying tissue, thus correcting
refractive error and improving visual acuity. While
patients are typically satisfied with outcomes after their
procedure [2,3], side effects do occur, mainly in the form* Correspondence: RLevitt@med.miami.edu
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unless otherwise stated.of unpleasant ocular sensations described as dryness,
burning, and discomfort. [4,5] These symptoms, regarded
as components of dry eye, range in severity, but the effects
on quality of life may be significant. Utility studies are
used to quantify patient experiences and preferences
regarding a disease state, and by this metric moderate-to-
severe dry eye symptoms are equivalent to moderate-to-
severe angina or hospital dialysis, while mild dry eye
symptoms might equate with severe migraines [6]. There
is a growing literature suggesting that these manifestations
of ocular discomfort, commonly described as symptoms of
“dry eye,” are better understood as corneal pain. The
International Association for the Study of Pain defines
pain as “an unpleasant sensory and emotional experience
associated with actual or potential tissue damage, orhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Levitt et al. Molecular Pain  (2015) 11:21 Page 2 of 12described in terms of such damage,” [7] a broad definition
which certainly encompasses the experience of those with
the “dry eye” symptoms described above. Furthermore,
there is much evidence to support the rationale that the
persistent ocular pain that some patients experience fol-
lowing LASIK is a manifestation of corneal neuropathy
and the development of central sensitivity.
Qualitatively, the symptoms described following
LASIK that have traditionally been conceptualized as
“dry eye” are similar to other forms of persistent pain
after nerve injury, suggesting that ocular surface pain
that develops after LASIK represents a pathological
hypersensitivity of the ocular somatosensory nerves. De-
scriptors frequently endorsed by patients with chronic
pain after nerve injury include burning and certain
forms of evoked pain (by touch, heat, or cold), pain due
to light touch or other innocuous stimuli (allodynia),
increased sensitivity to noxious stimuli (hyperalgesia),
and expansion of this heightened pain sensitivity beyond
the area of initial injury (secondary hyperalgesia) [8,9].
In the eye, these fundamental properties remain with
unique elicitors, for example, allodynia to wind, saline
eye drops, or light (photoallodynia or photophobia), and
the presence of spontaneous pain and dysesthesias (burn-
ing). Secondary hyperalgesia also occurs, and patients with
corneal neuropathic pain may experience exaggerated
conjunctival or scleral pain, in addition to pain along the
V1/V2 distribution (including exacerbation of migraine
headaches, pain over the face, temporomandibular joint,
cheek, etc.) [4,7,10-12]. Additionally, these symptoms of
ocular surface pain may be present without detectable
disruption of tear film parameters and accompanied by
normal or near normal corneal staining patterns, which
are used as indicators of corneal surface pathology [11,13].
Both acute and long–term ocular pain and discomfort
following LASIK have been reported [6,14,15]. It is sug-
gested that almost all patients have at least mild symptoms
after their procedure and that 20-55% of patients have per-
sistent symptoms, defined as symptoms at 6 months or
more post-procedure (Table 1) [13,14,16-20].Table 1 Incidence of chronic dry eye symptoms after refractiv
Study Procedure N Design
Denoyer 2014 [18] LASIK 60 Prospective series
De Paiva 2006 [19] LASIK 35 Prospective random
(nasal vs. superior h
Shoja 2007 [14] LASIK 95 Retrospective series
Donnenfeld 2003 [20] LASIK 52 Prospective random
(nasal vs. superior h
Tuisku 2007 [13] LASIK 20 cases Retrospective case-
Hovanesian 2001 [16] LASIK and PRK 781 Mailed questionnai
LASIK = laser in-situ keratomileusis, PRK = photorefractive keratectomy.LASIK induced damage of corneal innervation
Corneal neuroanatomy and pain transmission
The cornea is innervated by branches of the nasociliary
nerve, a branch of V1, the ophthalmic division of the tri-
geminal nerve. The nerves enter the periphery in a radial
fashion and lose their myelin sheath near the limbus, the
junction of the cornea and the sclera [21]. The majority
of the corneal nerve fibers (the sub-basal nerve plexus)
are located in the anterior third of the stroma and even-
tually turn 90 degrees to interdigitate between the cells
of the superficial epithelium very near to the ocular
surface [21]. Corneal nociceptors have their primary cell
bodies in the trigeminal ganglion and first synapse in the
trigeminal subnucleus interpolaris/subnucleus caudalis
(Vi/Vc) transition zone, and in the subnucleus caudalis/
upper cervical transition zone (Vc/C1–2) [22,23]. Second-
order axons originate from the spinal trigeminal nuclear
complex, decussate, join the contralateral spinothalamic
pathways, and synapse in the thalamus. Third-order neu-
rons then relay information to the supra-spinal centers, in-
cluding subcortical regions and the somatosensory cortex.
Furthermore, descending modulatory pathways exist, ori-
ginating in various areas of the central nervous system,
which modulate the signals of incoming pain and thus
pain perception. Corneal nerve damage is expected to alter
these ascending and descending pathways representing
the substrate of chronic pain (Figure 1).
Mechanisms of corneal neurotransmission that may be
altered by LASIK
Corneal nociceptors are present in 3 distinct types:
roughly 20% are Aδ mechanoreceptors transmitting
acute pain; 70% are polymodal, and 10% are C-fiber cold
receptors. There is also evidence that there may be
another class of receptors that are activated only by local
inflammation [24]. The Aδ mechanoreceptor neurons
are the fastest conducting, and appear to primarily trans-
mit signals in response to mechanical insults to the ocu-
lar surface and may be responsible for the sharp type
pain elicited by a foreign body [25]. Polymodal receptore surgery
Definition Incidence
Use of eye drops at 6 months 43%
ized
inge)
Fluorescein staining score of 3 or more
at 6 months
36.4% (overall)
Subjective symptoms at 6 months 20%
ized
inge)
Patients reporting eyes drier than before
LASIK at 6 months
31% (overall)
control Subjective symptoms at 2 - 5years 55%
re Subjective symptoms at 6 months or more 44%
Figure 1 A simplified version of the ocular sensory apparatus. First order neuron (red solid line) with nerve ending in the cornea, cell body in
the trigeminal ganglion, and synapse in the subnucleus caudalis. In actuality, however, there are multiple synapses for each nociceptor in the
trigeminal subnucleus interpolaris/subnucleus caudalis (Vi/Vc) transition zone, and in the subnucleus caudalis/upper cervical transition zone
(Vc/C1–2). Second order neurons (red dashed line) decussate and join the contralateral spinothalamic pathways and synapse in the thalamus.
Third-order neurons (red dashed line) then relay information to the supra-spinal centers, including the somatosensory cortex. Reproduced with
permission from Ocul Surf. 2012 Jan;10(1):2–14.
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thermal, and chemical stimuli as well as endogenous
mediators. Pathologic sensitization of this fiber type,
likely mediated in part by transient receptor potential
(TRP) receptors, including the TRP vanilloid receptor,
TRPV1, are believed to play a role in the pathogenesis of
neuropathic pain subsequent to corneal nerve injury.
Polymodal receptors are also believed to play a role in
reflexive tearing subsequent to irritation of the corneal
surface [24,25]. Finally, highly sensitive to changes in
corneal surface temperature down to 0.5°C, the C-fiber
cold thermoreceptors play an important role in mainten-
ance of basal tear secretion (as opposed to the induced
tear secretion mediated by polymodal receptors). Tonic
firing occurs in the setting of normal corneal/conjunc-
tival temperature of 34-35°C. As the tear film evaporates
in the absence of blinking, ocular surface temperature
falls by roughly 0.3°C per second and the firing rate in-
creases, eventually stabilizing at a higher frequency pro-
portional to the current corneal temperature [25-27]. As
occurs elsewhere in the body, the magnitude of excita-
tory input is likely dependent on both the frequency offiring and the total volume of activated receptors. Thus,
if the overall population of afferent fibers decreases, such
as in cases of corneal disease, aging, or perhaps after
refractive surgery, cold-dependent basal tearing would
be expected to decrease. The thermoregulation of these
fibers is largely mediated by TRPM8, a cold-gated ion
channel. TRMP8 −/− knock out mice were found to
have half the basal tear secretion of their wild-type
counterparts, providing evidence for the idea that tonic
firing of these receptors plays an important role in main-
taining basal tear secretion. These mice had preserved
irritation-induced tearing, a phenomenon mediated by
polymodal receptors independent of the TRPM8 channel
(as discussed above). Besides the three primary classes of
corneal nerve fibers, there are also distinct populations
defined by neurochemical markers, which are summarized
in Table 2, adapted from the text of Shaheen et al. [24].
Persistent sub-basilar plexus damage after LASIK
By virtue of its procedure (cutting a flap and ablating the
cornea underneath), LASIK leads to damage to the cor-
neal nerves of the sub-basilar plexus and decreased
Table 2 Select neurochemical markers of the cornea,
adapted from Shaheen et al., 2014 [24]
















NF-200 = neurofilament-200 kDa, CGRP = calcitonin gene-related peptide,
SP = substance P, PACAP = pituitary adenylate cyclase activating peptide,
FRAP= fluoride-resistant acid phosphatase, NE = norepinephrine, 5-HT = serotonin,
NPY = neuropeptide Y, Ach = acetylcholine, VIP = vasoactive intestinal peptide.
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of patients experience corneal hypoesthesia, which returns
to normal values by 6–12 months in some [14,28,29] (but
not all [30-36]) studies. However, although corneal sensi-
tivity may normalize, there is potentially permanent dam-
age of the sub-basilar nerve plexus; in studies with up to
5 years post-operative follow up, sub-basilar nerve plexus
density has never been demonstrated to return to pre-
LASIK levels [13-15,18,37-42]. In a small prospective,
non-comparative case series of 48 patients who underwent
bilateral LASIK, both corneal and conjunctival sensation
were significantly decreased from preoperative levels up to
16 months following the procedure. This hypoesthesia was
initially associated with both increased symptom severity
scores (dry eye symptoms including pain) and signs of
ocular surface pathology (abnormal Schirmer’s, corneal
staining). However, although objective signs of ocular
surface damage returned to baseline levels by 12 months,
symptoms remained significantly elevated from baseline at
16 months (the final time point) [32]. This correlation
between corneal hypoesthesia and symptom severity has
been reported in multiple studies in both post-LASIK and
idiopathic dry eye patients [43-46]. Another study of 20
LASIK patients also reported chronic symptoms without
objective corneal abnormalities at 2–5 years post-
procedure [13]. The persistence of pain in absence of ob-
jective peripheral findings is a pattern consistent with the
development of ocular neuropathic pain, and seen in
neuropathic pain syndromes elsewhere in the body.Likewise is the seemly paradoxical finding of decreased
corneal sensation with findings of increased pain and irri-
tation (e.g., as seen in diabetic and other neuropathies).
Mechanisms of pathologic neuroplasticity following LASIK
induced injury
The development of neuropathic ocular pain is likely a
consequence of the neuroplastic changes that occur after
ocular nerve injury induced by LASIK. This neuro-
remodeling has been well described, and involves per-
ipheral and central pathways as well as descending
modulation.
Peripheral sensitization is essentially the phenomenon
of nociceptor hyperexcitability following injury. Periph-
eral sensitization involves enhanced ion channel activa-
tion and conductance, increased expression of receptors
and channels on the cell membrane, and changes in
gene expression induced following neurogenic inflam-
mation in response to local injury. Collectively, these
changes result in the reduced threshold and increased
responsiveness of peripheral nociceptive neurons to the
stimulation of their receptive fields [7,47].
Prolonged firing of peripheral nociceptors can also re-
sult in neuroplastic changes to the central nervous sys-
tem, a process known as central sensitization. As in the
periphery, the bombardment of nociceptive input results
in modulation of neurotransmitter release, increases in ion
channel and receptor responsiveness and density, and
other changes (including alterations in cytosolic signaling
pathways), again mediated by inflammatory molecules in-
cluding cytokines, chemokines, and neuropeptides. Some
component of this process has been shown to have an N-
methyl-D-aspartate (NMDA) receptor dependent mech-
anism. Again, the end result is increased responsiveness of
nociceptive neurons in the central nervous system to their
normal or subthreshold afferent input [7,48]. A hallmark
of central sensitization is pain that is disconnected from
ongoing peripheral input, a phenomenon commonly seen
after LASIK in patients whose symptoms do not mirror
objective ocular surface findings, or “pain without stain”
[32,49]. The process of central sensitization may initially
be reversible, but often becomes permanent [50,51].
The dorsal horn, or in the case of the cornea, the
analogous trigeminal nucleus, is an intermediary be-
tween the higher central processing centers and periph-
eral nervous systems, home to the convergence of the
circuits critical to the regulation of descending inhibitory
modulation, and a key locus in the process of central
sensitization [50,51]. The allodynia characteristic of
neuropathic pain is thought to originate here with the
recruitment of Aβ and C fibers and phenotypic switch
from innocuous touch to pain transmission. The dorsal
horn/spinal trigeminal nuclei represent an important
clinical target, as it is here that opioids, serotonergic and
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many of their effects to reduce neuropathic pain by
reducing excitatory synaptic neurotransmission (acting
presynaptically) and/or by enhancing inhibitory modula-
tion. Additional supraspinal mechanisms modulating
pain up to and including the cortex have also been
described [47].
Persistent post-surgical pain after LASIK: What can we
learn from other PPP disorders?
Persistent post-surgical pain (PPP) is a known entity that
can occur after any surgical intervention, and nerve
injury is believed to be the major cause. Typically, this
entity is considered to be present in patients with (1)
pain that developed after surgery, (2) pain of at least 3–6
months duration (well after sufficient time for healing of
those tissues disrupted by surgery), (3) other causes of
pain excluded, (4) pain of neuropathic quality (burning,
shooting, electric-like), and (5) pain that occurs spontan-
eously, or in the absence of nociceptor activation [47].
Clinical signs of hyperalgesia (or expansion of receptive
fields as in secondary hyperalgesia) or allodynia com-
monly help to substantiate diagnosis of neuropathic
pain. There is substantial overlap in the risk factors and
epidemiology of post-LASIK eye pain and somatic PPP
syndromes, as would be expected if chronic dry-eye type
symptoms after LASIK are manifestations of persistent
neuropathic ocular pain.
Risk factors for the development of PPP after opera-
tions such as amputation, breast surgery, thoracotomy,
herniorrhaphy, coronary artery bypass, and cesarean sec-
tion include female gender (where applicable), younger
age, presence and severity of persistent pre-operative
pain, severity of post-operative pain, type of surgery, and
genetic factors [52]. Many similar risk factors have also
been found in dry eye after LASIK and dry eye in gen-
eral. A study examining risk factors for the development
of dry eye after LASIK found female sex, higher refract-
ive correction, and greater ablation depth to be risk fac-
tors for the development of dry eye at 6 and 12 months
post-operation [14], however another study did not iden-
tify gender as a risk factor [19]. Pre-existing dry eye
symptomatology is another risk factor for severe or pro-
longed dry-eye following LASIK [6]. There is also evi-
dence establishing the heritability of “primary” dry eye,
that is, dry eye unrelated to ocular surgery. The genetics
of susceptibility to post-operative dry eye/persistent ocu-
lar pain have yet to be extensively studied. However,
functional variants in proinflammatory cytokines may be
important in susceptibility to primary dry eye [14]. In
addition to overlapping risk factors, the estimated inci-
dence of chronic symptoms after LASIK fits nicely
within the range expected of other PPP syndromes.
Somewhere between 20-55% of LASIK patients will goon to develop at least mild symptoms of dry eye/persist-
ent ocular pain, which overlaps with the expected inci-
dence of PPP after breast surgery, coronary artery
bypass surgery, amputation (30-50%), and thoracotomy
(30-40%) [52-62].
As alluded to above, the epidemiology of PPP has been
evaluated in a variety of surgical procedures and wide
ranges have been found for its incidence depending on
the surgery and method of ascertainment (Table 3)
[55,59,61,63-70]. Certain surgeries, such as mastectomy
and thoracotomy, have also been found to have a higher
incidence of PPP. Thoracotomy in particular has been
associated with extensive intercostal nerve damage, the
degree of which has been found to correlate with the
severity of PPP [52]. Since the development of PPP is
generally related to nerve injury, it seems reasonable that
surgical techniques to minimize nerve damage may
reduce its incidence. There are multiple examples of this
[52]. Laparoscopic herniorrhaphy can reduce the risk of
nerve damage and pain as compared to an open proced-
ure [52,71]. Muscle sparing thoracotomy results in less
nerve damage and a reduction in PPP incidence as com-
pared to a posterolateral approach [52,72]. During mast-
ectomy, it has also been observed that preservation of
the intercostobrachial nerve reduces chronic pain inci-
dence [52,67,73]. Likewise, there is evidence that the in-
cidence of persistent post-LASIK ocular pain symptoms
differs based on surgical technique. Location of the cor-
neal flap hinge is one variable that has been investigated.
Some studies report an increase in symptoms, along
with reduced corneal sensation, with a superior as com-
pared to nasal hinge location during the creation of the
corneal flap [20,74]; however, others have found no
differences by hinge position [31,33,75,76]. The rationale
behind these investigations relates to corneal neuroanat-
omy: because the corneal nerves predominately enter
the cornea at 3 and 9 o’clock positions, the nasal hinge
transects just one of these areas, while the superior
hinge severs both [20]. A 2012 meta-analysis of 8 ran-
domized controlled trials (ranging from n = 35 to 212)
found that hinge location may have some effect on early
post-operative dry eye and corneal sensation, but found
no difference by 6 months post-operatively [77]. The use
of femtosecond laser versus keratome for corneal flap
creation has also been investigated. One study of 183 pa-
tients randomized to either microkeratome of femtosec-
ond laser found the incidence of dry eye signs and
symptoms to be significantly lower in the laser group,
however more recent, smaller studies have found no dif-
ference [78-80]. Surgical optimization to prevent corneal
nerve injury (to the extent possible) due to LASIK re-
mains an open question.
Difference in morbidity associated with LASIK versus
photorefractive keratectomy (PRK) has also been
Table 3 Incidence of persistent post-surgical pain after different surgical interventions
Study Surgery N Design Definition Incidence
Brandsborg 2007 [65] C-section 1173 Questionnaire 1 year after surgery Pain 31.9% at 1 year
Brander 2003 [64] Total knee replacement 116 Prospective longitudinal Significant pain (VAS > 40) 13.1% at 1 year
Inaba 2012 [59] Inguinal hernia repair 191 Questionnaire Any pain 14.7% at variable time points least
3 months after surgery
Oberg 2005 [61] Laparoscopic inguinal herniorrhaphy 161 Questionnaire Chronic pain; unclear definition 4% at variable time points
Duale 2014 [67] Elective C-section, inguinal herniorrhaphy,
breast cancer surgery, cholecystectomy,
saphenectomy, sternotomy, thoracotomy,
or knee arthroscopy
2397 Multicenter prospective longitudinal 4 items positive on DN4 All (20.6%); laparoscopic herniorrhaphy
(3.2%); knee arthroscopy (15.8%); C-section
(24.5%); thoracotomy (32.7%); breast
cancer surgery (37.1%) at 6 months
Ilfeld 2014 [68] Mastectomy 30 Prospective longitudinal Brief pain inventory pain induced dysfunction 47% at 12 months
Liang 2013 [69] Ventral hernia repair 122 Retrospective Unclear definition categorical variable 17.2% at variable time points
Nikolajsen 2004 [70] C-section 220 Questionnaire mean follow-up
time 10.2 months after surgery
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refractive error; however, unlike LASIK, it does not
utilize a corneal flap and the corneal surface is ablated
directly to reach the stroma beneath. A prospective
study published in 2000 demonstrated a greater reduc-
tion in tear secretion in LASIK versus PRK patients at
6 months post-operatively, however this study looked
only at objective signs and not symptoms of ocular pain
[81]. A more recent study prospectively compared the
incidence of dry eye symptoms in 34 patients with one eye
receiving LASIK and the other PRK, concluding that at
12 months there was no increase in dry eye symptoms
over pre-operative baseline in either group. However,
although uniquely controlled with the use of both tech-
niques in each patient, with a sample size of only 34, it is
not clear that the study is sufficiently powered to draw
conclusions regarding the incidence of dry eye [82].
Neuropathic ocular pain after LASIK: implications for
prevention and treatment of persistent symptoms
If one accepts the idea that neuropathic ocular pain at
least partially underlies persistent dry eye symptoms
after LASIK, this opens up a new realm of possibilities
for prevention and treatment. Since, as far as we are
aware, no studies have been conducted to comprehen-
sively evaluate pharmacological treatment efficacy for the
prevention of persistent ocular pain following LASIK in
humans, we rely on what is known about the treatment of
PPP in other areas of the body, and will mention relevant
studies applying these well-established findings to the pre-
vention of neuropathic pain in the eye.
Gabapentin and pregabalin (referred to collectively as
“gabapentinoids”) are mainstays in the treatment of
neuropathic pain. As discussed previously, the modula-
tion of sensitization processes in the dorsal horn is a key
target for pharmacologic treatment of PPP. The gaba-
pentinoids bind to the regulatory alpha-2 delta (α2δ)
subunit of N-type voltage gated calcium channels in dor-
sal root ganglia, in the dorsal horn and periaqueductal
gray, with the ultimate effect of reducing excitatory
neurotransmission [47,83]. There is also evidence for
antagonism of the NMDA receptor, which, as previously
discussed, may play a role in the process of central
sensitization. In addition to these central actions, gaba-
pentin has also been shown to reduce discharge from
injured peripheral nerves [84].
Schmidt et al. nicely summarized that gabapentin has
been shown to decrease the incidence of PPP after many
but not all surgical procedures in randomized, placebo-
controlled trials [85]. Surgeries where gabapentinoids
had a positive effect included abdominal hysterectomy,
herniorrhaphy, thyroidectomy, mastectomy, knee arthro-
plasty, cardiac surgery, and lumbar discectomy [85].
Dosing strategies ranged from high dose pre-operativeadministration only, to a low pre-operative dose followed
by an extended taper [85-88] (Table 4).
Regarding LASIK and the related vision correction pro-
cedure, PRK, the gabapentinoids have only been studied in
the context of short term post-operative pain, and have
been shown to decrease immediate post-operative pain
following PRK in 2 of the 3 [89-92] prospective, random-
ized control trials to date. The largest of these studies (n =
150) demonstrated the positive effect of the gabapenti-
noids and demonstrated the equivalent effectiveness of
gabapentin and pregabalin. However, these studies of
immediate post-operative pain would not capture the later
effects of this drug, and it is important to note that many
studies of gabapentinoids in PPP prevention find this class
more effective at reducing the risk of late but not immedi-
ate post-operative pain [86,93].
In addition to the gabapentinoids, opioids, alpha-2 ad-
renergic agonists, anti-depressants (specifically tricyclic
and serotonin norepinephrine reuptake inhibitor classes
of anti-depressants), and NMDA antagonists (ketamine)
have also been used with success to treat chronic neuro-
pathic pain. Local anesthetics have also been shown to
reduce PPP by blocking peripheral input to the central
nervous system [47].
Several topical agents, both targeting nerve growth and
inhibiting inflammation, have been found to improve cor-
neal sensitivity and nerve regeneration after LASIK in
animal models. For example, topical insulin-like growth
factor-1 (IGF-1) had positive effects on corneal surface
ultrastructure, nerve regeneration, and tear parameters
compared to controls in a rabbit model of LASIK [94]. In a
similar model, both macrophage migration inhibitory fac-
tor and a combination of nerve growth factor (NGF),
neurotrophine-3, interleukin-6, and leukemia inhibitory
factor improved corneal sensitivity (via Cochet-Bonnet
esthesiometer) in a more rapid manner compared to con-
trols [95]. Another rabbit study found that eyes treated
with NGF demonstrated an earlier and faster recovery of
corneal sensitivity after LASIK compared to balanced salt
treated controls [96]. These agents have not been evaluated
in humans, however a 2005 study of 35 patients did find a
correlation between higher levels of tear fluid NGF and
improved corneal sensation in PRK as opposed to LASIK
patients [97].
Autologous serum eye drops have been used for tear
replacement in patients with severe dry eye. These tears
are believed to be enriched with neurotrophic factors
that could aid in nerve healing, including NGF [98].
Despite the theoretical potential of this treatment, in a
prospective, randomized study of 54 eyes (27 male pa-
tients) undergoing LASIK, although improvement of
some ocular signs of dry eye were reported in the experi-
mental group, no differences were noted in the subject-
ive scores for dryness between patients using autologous
Table 4 Prevention of chronic post-operative pain with perioperative gabapentin and pregabalin: randomized,
placebo-controlled studies
Study Surgery Metric of pain assessment Treatment Outcome
Fassoulaki 2005 [86] Breast surgery
for cancer
Presence of pain (yes vs no) Gabapentin (400 mg q6h, started 12 h
pre-op, continued to POD 8, local
anesthetic cream, and ropivacaine in
wound (n = 25) vs placebo (n = 25)
Non-significant trend to less
pain (30% vs 57%) and anesthetic
use (0% vs 19%) at 6 months
Buvanendran 2010 [87] Total knee
arthroplasty
Neuropathic pain via Leeds
Assessment of Neuropathic
Symptoms and Signs scale
Pregabalin (300 mg) (n = 113)
vs placebo (n = 115)
Significantly reduced pain in
pregabalin group (0% at 3 &
6 months) vs placebo (8.7% and
5.2% at 3 & 6 mo).
Sen 2009 [88] Elective
hysterectomy
Verbal rating scale scores Gabapentin 1.2 g w/placebo infusion
(n = 20); ketamine w/oral placebo
(n = 20); Control group (n = 20)
Significantly reduced pain scores
in gabapentin group vs ketamine &
placebo at 6 months
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tears groups [99]. However, it bears mentioning that at
this sample size, this study is underpowered to detect
anything other than a very large effect size, and a larger
study would be needed to detect mild to moderate
improvement.
Moving forward, LASIK offers an ideal elective surgi-
cal model in which to study the factors influencing the
development of PPP. The benefits of this model would
be multiple. Because of the elective nature of the pro-
cedure, we know when the surgery is going to occur,
allowing us to monitor both pre- and post-operatively
for environmental and genetic risk factors (such as dry
eye symptoms, central sensitivity, or chronic pain syn-
dromes), as well as perform corneal, facial, and general-
ized quantitative sensory testing before and after
surgery, allowing us to define the natural history of dis-
ease development in susceptible individuals. The elective
nature of the procedure (and the frequency with which
it is performed) also facilitates the design of randomized
controlled trials of reasonable size and appropriate
power to detect differences due to risk factors, the efficacy
and safety of potential treatments, and the pharmacogen-
omics of treatment response. Additionally, LASIK is gen-
erally performed according to a standardized protocol
where nerve damage is expected to be reproducible. The
corneal sub-basal nerve plexus is also uniquely accessible
to the researcher, and may be easily visualized with con-
focal microscopy.
Shared susceptibility factors may underlie persistent
post-surgical pain, including LASIK
Virtually all disease arises from the interaction between
genetic susceptibility and environmental factors, and the
emergence of persistent ocular pain following refractive
surgery is likely no different. Potential environmental
triggers influencing outcomes may include surgical ap-
proach, including hinge location and size, type of pro-
cedure (LASIK versus PRK), and even, as some experts
have suggested, stress and chemical exposure (such asthat to alcohol, drugs, and environmental toxins) [100].
Genetics is also believed to play an important role in de-
termining the clinical variability observed in nociception,
pain processing, and therapeutic response [101,102].
These genetic factors may represent a blueprint for pre-
disposition to chronic pain syndromes, including PPP as
it manifests after LASIK.
Functional DNA variants (genetic polymorphisms) are
known to impact neuronal function and inflammation,
and are therefore likely to modulate the clinical presen-
tation of PPP after LASIK and affect symptom onset and
severity. While there are only a few reports on genetic
polymorphisms and symptoms of primary DE, substan-
tial research supports the fact that relatively common
inherited genetic polymorphisms underlie individual dif-
ferences in pain perception [102], pain related behaviors
and the development of persistent pain syndromes
[100,103]. For example, COMT (Catechol-O-methyl
transferase) is an important gene whose functional vari-
ants have been described in over 100 publications and
30 reviews. COMT variants are associated with various
forms of pain including neuropathic pain, post-surgical
pain, and post-surgical pain severity [104-110]. Other
gene variants found to be associated with PPP include
the HLA genotype DRB1*04 and DQB1*03:02 allele,
both of which are associated with chronic pain after in-
guinal hernia repair (n = 189) and lumbar disc herniation
(n = 258) [111]. Genetic variants in voltage-gated sodium
channels, GTP cyclohydrolase and tetrahydrobiopterin
have also demonstrated an association with PPP [47].
In another study, 1 cytokine gene polymorphism
(interleukin [IL] 1 receptor 2 single nucleotide poly-
morphism [SNP] rs11674595) and 1 haplotype (IL10
haplotype A8) were associated with PPP after breast
cancer surgery [112]. Inflammation is also an important
component of dry eye and polymorphisms in the proin-
flammatory cytokine genes IL-1β (SNP rs1143634) and
IL-6R (SNP rs8192284) have been reported to associate
with non-Sjogren dry eye symptoms in a Korean popula-
tion [113]. This finding makes intuitive sense, as
Levitt et al. Molecular Pain  (2015) 11:21 Page 9 of 12inflammation of the ocular surface together with a genetic
propensity for inflammation can profoundly influence
neuroplasticity and contribute to neuronal dysfunction
and neuropathic pain [114-116]. With only limited infor-
mation available, more research is needed on genetic sus-
ceptibility and epigenetic alterations associated with the
severity and persistence of dry eye symptoms, including
those emerging after LASIK.
Recently, a large twin study demonstrated that shared
genetic factors underlie a number of comorbid chronic
pain conditions, including chronic widespread musculo-
skeletal pain, pelvic pain, irritable bowel syndrome, and
dry eye, and that this latent genetic factor had an esti-
mated heritability of 66%. This finding supports the no-
tion of common pathways of susceptibility and an
underlying genetic disposition to developing chronic
pain [117]. Our own data further expands on this by
demonstrating that presence of neuropathic ocular pain
(again, as manifests with “dry eye” type symptoms) in an
individual is strongly associated with the presence of 3
or more comorbid pain disorders (unpublished observa-
tions of 115 patients with mild to moderate dry eye).
With these studies, we have just begun to elucidate the
mechanisms of heritable predisposition to the development
of these syndromes including dry eye. Genomic studies to
identify functional variants in genes and biologic pathways
critical to disease susceptibility and resistance will be crit-
ical moving forward, with the hope that these types of
studies will allow us to better understand the mechanism
of the development of PPP syndromes using LASIK as a
prototype, and potentially lead to the discovery of prevent-
ive approaches and mechanism-based treatments.
Conclusions
With this review we have attempted to make three major
points. First, that perhaps the experience of persistent dry
eye symptoms following LASIK is better conceptualized as
a neuropathic ocular surface pain syndrome involving
mechanisms of both peripheral and central sensitization.
Second, given this and the well-established evidence re-
garding injury to corneal nerves during the LASIK proced-
ure, we may look to other PPP syndromes as the prototype
for the management of persistent neuropathic ocular pain
following LASIK procedures, and should revisit the use of
existing neuromodulators for prevention and treatment in
well-controlled randomized trials that are appropriately
powered to assess efficacy and safety of known and novel
approaches. Third, that the development of PPP in the eye
or anywhere else in the body is the product of the inter-
action of genetic and environmental factors, and that un-
derstanding the genetics of susceptibility to these disorders
will be important in realizing novel preventative and mech-
anism based treatments. We believe that it is important to
better define the role of anti-neuropathic pain treatment inmodulating ocular sensory apparatus function in patients
with this symptom complex, and to integrate this tactic
into a multi-modal approach including the treatment of
ongoing ocular surface damage with ocular surface protec-
tion and anti-inflammatory agents. Furthermore, agents
such as the gabapentinoids, may be promising in reducing
the likelihood of development of central sensitization by
attenuating the afferent trafficking of pain signals and
excitatory synaptic transmission.
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